Inventor profile of:

Michael PACKER

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

26

Last publication date:

2026-06-04

Top Assignees for applications by Michael PACKER

The entities that hold a legal rights for patent applications filed by inventor PACKER Michael:

Recent patent applications by PACKER Michael

Michael PACKER from Cambridge, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-06-04
US20260151508A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING ALPHA-1 ANTITRYPSIN DEFICIENCY

#2 | 2026-04-23
US20260108590A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING HEMOGLOBINOPATHIES

#3 | 2026-03-05
US20260061041A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING HEMOGLOBINOPATHIES

#4 | 2025-04-03
US20250108098A1
Human necessities

METHODS OF SUBSTITUTING PATHOGENIC AMINO ACIDS USING PROGRAMMABLE BASE EDITOR SYSTEMS

#5 | 2024-09-12
US20240301405A1
Chemistry; metallurgy

GUIDE RNAS FOR CRISPR/CAS EDITING SYSTEMS

#6 | 2024-07-11
US20240228988A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR EFFICIENT GENOME EDITING

#7 | 2024-04-25
US20240132867A1
Chemistry; metallurgy

ADENOSINE DEAMINASE BASE EDITORS AND METHODS OF USING SAME TO MODIFY A NUCLEOBASE IN A TARGET SEQUENCE

#8 | 2024-04-11
US20240117345A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING TRANSTHYRETIN AMYLOIDOSIS

#9 | 2023-11-30
US20230383277A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISEASE TYPE 1A

#10 | 2023-05-25
US20230159956A1
Chemistry; metallurgy

METHODS OF EDITING SINGLE NUCLEOTIDE POLYMORPHISM USING PROGRAMMABLE BASE EDITOR SYSTEMS

#11 | 2023-05-11
US20230140953A1
Human necessities

METHODS OF EDITING A DISEASE-ASSOCIATED GENE USING ADENOSINE DEAMINASE BASE EDITORS, INCLUDING FOR THE TREATMENT OF GENETIC DISEASE

#12 | 2023-04-27
US20230128472A1
Human necessities

Compositions and methods for treating hemoglobinopathies

#13 | 2023-03-30
US20230101597A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING ALPHA-1 ANTITRYPSIN DEFICIENCY

#14 | 2023-03-16
US20230080198A1
Chemistry; metallurgy

MODIFIED IMMUNE CELLS HAVING ADENOSINE DEAMINASE BASE EDITORS FOR MODIFYING A NUCLEOBASE IN A TARGET SEQUENCE

#15 | 2023-03-09
US20230075877A1
Chemistry; metallurgy

NOVEL NUCLEOBASE EDITORS AND METHODS OF USING SAME

#16 | 2023-03-09
US20230070861A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B

#17 | 2022-12-22
US20220401530A1
Human necessities

Methods of substituting pathogenic amino acids using programmable base editor systems

#18 | 2022-11-24
US20220370575A1
Human necessities

Compositions and methods for treating hemoglobinopathies

#19 | 2022-07-28
US20220235347A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING HEMOGLOBINOPATHIES

#20 | 2022-04-28
US20220127594A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISEASE TYPE 1A

#21 | 2022-03-31
US20220098593A1
Chemistry; metallurgy

SPLICE ACCEPTOR SITE DISRUPTION OF A DISEASE-ASSOCIATED GENE USING ADENOSINE DEAMINASE BASE EDITORS, INCLUDING FOR THE TREATMENT OF GENETIC DISEASE

#22 | 2021-12-09
US20210380955A1
Chemistry; metallurgy

METHODS OF EDITING SINGLE NUCLEOTIDE POLYMORPHISM USING PROGRAMMABLE BASE EDITOR SYSTEMS

#23 | 2021-12-02
US20210371858A1
Chemistry; metallurgy

METHODS OF SUPPRESSING PATHOGENIC MUTATIONS USING PROGRAMMABLE BASE EDITOR SYSTEMS

#24 | 2021-08-26
US20210261955A1
Chemistry; metallurgy

Compositions and methods for treating hemoglobinopathies

#25 | 2021-08-19
US20210252118A1
Human necessities

Compositions and methods for treating hemoglobinopathies

#26 | 2021-05-06
US20210130805A1
Chemistry; metallurgy

Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence

InventorID:

5070060 ⎘